Artrite reumatóide é uma doença auto-imune que apresenta acentuado quadro inflamatório e proliferação celular o que, provavelmente, determina a alta prevalência de doenças cardiovasculares quando comparados a população mundial. A mortalidade e a morbidade conseqüentes das doenças cardiovasculares estão 2 vezes aumentadas em pacientes com artrite reumatóide e um dos principais fatores de risco relacionados ao desenvolvimento da aterosclerose é a dislipidemia. Esse importante fator de risco vem sendo associado à artrite reumatóide e as concentrações plasmáticas de lípides são constantemente avaliadas, já que se encontra bem estabelecido a relação entre dislipidemia e alta incidência de doença cardiovascular. No entanto, o verdadeiro impacto das alterações lipídicas na artrite reumatóide não é bem conhecido, já que os resultados de perfil lipídico são contraditórios. Alterações nas concentrações plasmáticas de lípides não necessariamente acompanham distúrbios no metabolismo das lipoproteínas plasmáticas. O objetivo do presente estudo foi avaliar aspectos do metabolismo da LDL e da HDL, em pacientes com artrite reumatóide. Nesse sentido, foi avaliada a cinética plasmática de uma nanoemulsão lipídica artificial com comportamento metabólico semelhante ao da LDL em 30 pacientes com artrite reumatóide divididos em 2 grupos de acordo com a atividade da doença, alta atividade (n=14) e remissão (n=16) e 30 indivíduos controle. A nanoemulsão marcada com éster de colesterol 14EC (EC-14C) e colesterol livre 3H (CL-3H) foi injetada endovenosamente após 12 horas de jejum. As amostras de sangue foram coletadas em tempos pré-determinados (5 min, 1, 2, 4, 6, 8 e 24 horas) após a injeção, para determinação das curvas de decaimento plasmático e da taxa fracional de remoção (TFR) dos lípides marcados, por análise compartimental. As TFR-EC-14C e TFR-CL-3H foram maiores no grupo AR quando comparado ao grupo controle (49%, p<0,05 e 44%, p<0,05, respectivamente), não havendo diferença entre os subgrupos de artrite reumatóide. No grupo artrite reumatóide e em seus subgrupos, as concentrações de HDL-C e apo E foram maiores quando comparados ao grupo controle (33%, p<0,0001 e 20%, p<0,01, respectivamente), enquanto os níveis de apo B foram menores na artrite reumatóide quando comparados ao grupo controle (16%, p<0,05). A transferência de colesterol esterificado radioativo da nanoemulsão para a HDL foi menor na artrite reumatóide, comparando-se com o grupo controle. A transferência dos outros lípides foi similar nos dois grupos. A HDL dos pacientes com artrite reumatóide foi menor do que a dos controles. Esses resultados podem contribuir com a melhor compreensão de possíveis mecanismos relacionados a uma maior incidência de doenças cardiovasculares em pacientes com artrite reumatóide / Mortality and morbidity, as a consequence of cardiovascular diseases, is twice as high in patients with rheumatoid arthritis than in the general worldwide population. This autoimmune disease has predominant inflammatory and cell proliferation background probably explains the high prevalence of cardiovascular disease. Dyslipidemias are important risk factors for cardiovascular disease. This study investigated the link between RA and plasma lipids as a predisposition to this high cardiovascular disease incidence. However, the impact of lipids on cardiovascular risk in rheumatoid arthritis is unclear. So much so, that lipid profiles in patients with rheumatoid arthritis in published studies is contradictory. The events of intravascular lipoprotein metabolism do not necessarily produce altered levels of plasma lipids. In an attempt to unravel novel dysfunctional mechanisms that could trigger pro-atherogenic processes beyond the concentration of the plasma lipids, plasma clearance of a lipidic nanoemulsion that resembles the LDL metabolic behavior were investigated in rheumatoid arthritis patients and compared to control subjects without the disease. 30 patients with rheumatoid arthritis divided into 2 groups according to disease activity, high activity (n=14) and remission (n=16), and 30 controls were studied. A nanoemulsion labeled with 14C-cholesteryl esther (14C-CE) and 3H-free cholesterol (3H-FC) were endovenously injected after which blood samples were collected at pre-determined periods (5 min, 1, 2, 4, 6, 8 and 24 hours), in order to determine the radioactivity of the plasma decay curves and calculate the fractional clearance rate (FCR) of the labeled lipids for compartmental analysis. In the rheumatoid arthritis group and subgroups the HDL-C and apo E concentration were higher when compared to control group (33%, p<0,0001 e 20%, p<0,01, respectively) while apo B concentration was lower (16%, p<0,05). The 14-CE-FCR and 3H-FC-FCR were greater in rheumatoid arthritis group and subgroups when compared to controls (49%, p<0,05 e 44%, p<0,05, respectively). There were no differences between the rheumatoid arthritis subgroups. Therefore, rheumatoid arthritis accelerates the LDL plasma removal, as indicated by a higher 14-CE-FCR and 3H-FC-FCR. The transfer of other lipids was also similar in both groups. The HDL of the rheumatoid arthritis patients was lower than that of the control group. These results could clarify possible mechanisms that can be related to a higher cardiovascular incidence in patients with rheumatoid arthritis

A artrite reumatoide (AR) é uma doença crônica autoimune que afeta as articulações e causa uma persistente inflamação sinovial e destruição da cartilagem e osso. A artrite induzida por pristane (PIA) em camundongos é um modelo experimental utilizado em muitos trabalhos, pois se assemelha à artrite reumatoide. MicroRNAs (miRNA) têm sido bastante estudados por sua participação no desenvolvimento da artrite. As linhagens de camundongos AIRmax e AIRmin, diferem quanto a susceptibilidade/resistência à PIA. Nós analisamos o perfil de expressão gênica de mRNA e miRNAs das células peritneais dessas linhagens e avaliamos sua participação no desenvolvimento da PIA. A linhagem AIRmax mostrou uma maior modulação de genes (2025) com relação aos AIRmin (1043) no início dos sintomas. Os miRNAs 132-3p/212-3p e 130b-3p foram, os miRNAs mais significativamente modulados nos animais sensíveis e mostraram correlações negativas com alguns de seus genes alvos preditos. Nosso estudo mostrou que a expressão de mRNAs e miRNAs é modificada nas linhagens AIRmax e AIRmin durante a PIA. / Rheumatoid arthritis is a chronic autoimmune disease that affects joints and it is characterized by synovial inflammation and articular cartilage and bone destruction. Pristane-induced arthritis (PIA) in mice is an experimental model that has been used in many studies, since it resembles rheumatoid arthritis. MiRNAs has been extensively studied in the development of arthritis. AIRmax and AIRmin lines, differ in their susceptibility/resistance to PIA. We analyzed the miRNA and gene expression profile of mRNA in peritoneal cells of these lines in order to evaluate their involvement in PIA development. AIRmax mice showed a high gene modulation (2025) than AIRmin mice (1043) at the onset of disease symptoms. The 132-3p/212-3p and 130b-3p miRNAs were the most significant in susceptible animals showing negative correlations with some of their predicted target genes. Our study showed that the global gene and miRNA expressions are modified in the peritoneal cells of AIRmax and AIRmin lines during pristane-induced arthritis.

Osteoporosis and fragility fractures are recognized complications of inflammatory rheumatic diseases. This is thought to result from the effects of chronic inflammation, relative immobility and corticosteroid use. A rare syndrome of osteoporosis in a patient with coeliac disease has been described which results from production of neutralizing antibodies to the bone protective protein osteoprotegerin (OPG). The aim of my thesis is to evaluate prevalence and clinical predictors of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis (RA) and to investigate the role of OPG autoantibodies in the pathogenesis of osteoporosis in rheumatic diseases. In a retrospective cohort study, I found that the overall prevalence of osteoporosis in patients with RA was 29.9% which is in keeping with older reports that recorded a prevalence rate between 17% and 36%. In our contemporary cohort osteoporosis was significantly more common than in a gender and age matched control cohort (17.4%). Further analysis showed that only age and BMI were independent predictors of osteoporosis in RA. A predictive tool based on age and BMI was developed which had 91.4% sensitivity for the detection of osteoporosis in an independent RA population. I went on to screen for the presence of autoantibodies to OPG in patients with various rheumatic diseases. In a study of 75 patients with rheumatoid arthritis and 199 healthy controls OPG autoantibodies were detected in two controls (1%) compared with seven patients with RA (9.3%). The RA patients with detectable OPG antibodies had a longer disease duration, higher DAS28 scores and higher levels of the bone resorption marker CTX than RA patients who did not have autoantibodies. Purified IgG from patients with high levels of OPG antibodies blocked the ability of recombinant OPG to inhibit RANKL induced NFκB activation in a HEK293 cell based assay indicating that they were functional. In a further study of 134 patients with ankylosing spondylitis (AS), 16 patients (11.9%) had detectable OPG antibodies. The presence of OPG-Ab was independently associated with reduced hip bone mineral density and an increased risk of fractures in this population. In patients with a longer disease duration we have also observed that there was a higher discrepancy between spinal and hip BMD in OPG-Ab positive patients compared with OPG ab negative patients (p=0.003). In order to investigate if OPG antibodies affected measurement of serum RANKL concentrations as detected by ELISA using OPG as the capture reagent, I measured OPG ab and free RANKL concentrations in 55 rheumatic disease patients. Surprisingly there was a significant positive correlation between free RANKL and OPG Ab concentrations (r=0.430, p=0.001) which was the opposite to what I had expected. These findings reject the hypothesis that OPG ab block binding of synthetic OPG to RANKL in the ELISA. In conclusion, I have shown that osteoporosis is a common complication in RA and I have developed a new risk prediction tool for the use in clinical practice. I have also found that OPG antibodies are produced more commonly in patients with RA and AS than in healthy controls and that antibody levels correlate with bone resorption markers in RA and bone mineral density in AS patients. In vitro studies have shown that some OPG antibodies have functional effects on RANKL signalling. These findings raise the possibility that OPG antibodies may contribute to the pathogenesis of local and systemic bone loss in rheumatic diseases and signal the need to study the relationship between these antibodies and bone disease in large-scale longitudinal studies.

A osteoartrose (OA) de joelho é uma das doenças osteomioarticulares mais comuns no mundo, afetando 2693 em cada 100.000 mulheres e 1770 em cada 100.000 homens. Embora o treinamento de força (TF) seja amplamente recomendado para a melhoria das debilidades físicas encontradas em pacientes com OA, o uso de cargas entre 70-85% da força dinâmica máxima (FDM) pode ser limitado não somente pela dor, mas também pela própria etiologia da doença, representando uma limitação para esta prática. O treinamento de força associado à oclusão vascular (TFOV) baseia-se na execução do TF em intensidades entre 20 e 50% da FDM, combinado à oclusão do fluxo sanguíneo através do uso de torniquetes. Estudos têm mostrado que a magnitude das mudanças na força e massa musculares após um período de treinamento com esta técnica é similar as causadas pelo TF de alta intensidade (70-85% FDM) sem adição da oclusão vascular. O objetivo do presente trabalho foi investigar a eficácia da associação da oclusão vascular ao TF como modelo de intervenção não farmacológica para melhoria da dor, força muscular, funcionalidade e qualidade de vida em pacientes diagnosticadas com OA de joelho. Diante disso, 48 participantes mulheres foram randomicamente distribuídas em três grupos: treinamento de força de baixa intensidade (TFB), treinamento de força de alta intensidade (TFA) ou treinamento de força de baixa intensidade associado à oclusão vascular (TFOV) e receberam treinamento duas vezes por semana durante doze semanas. No período basal e após a intervenção, as pacientes passaram por avaliações físicas (testes de funcionalidade e força), responderam questionários de qualidade de vida e de dor (índice WOMAC \"Western Ontario and McMaster Universities Osteoarthritis Index\" e SF-36 \"The Short Form 36 Health Survey\") e exame de imagem da área da secção transversa (AST) do músculo quadríceps por meio de tomografia computadorizada. Durante o período de treinamento, quatro pacientes do grupo TFA foram excluídas do protocolo por dor no joelho. Após a intervenção, no WOMAC, apenas os grupos TFOV e TFB apresentaram diminuições significativas na dor (p=0,0358 e p=0,0044, respectivamente), nos demais domínios, o único grupo que apresentou diminuições significativas de escore foi o TFOV (rigidez: p=0,0167 e funcionalidade p=0,0358). Nos testes de funcionalidade, os grupos TFOV e TFA apresentaram aumentos significativos no desempenho do \"Timed-stands test\" (p=0,0251 e p=0,003), no \"Timed-up-and-go\" não foram encontradas melhoras significantes nos grupos. Com relação a força, apenas os grupos TFOV e TFA aumentaram significativamente os valores no leg-press (p<0,0001) e na extensão de joelhos (p<0,0001). Comportamento similar foi encontrado no aumento da AST, grupos TFOV e TFA apresentaram aumentos significativos (p<0,0001). A melhora de qualidade de vida foi significante nos três grupos quando analisamos a somatória dos domínios do WOMAC (TFOV: p=0,0173; TFA: p=0,0438; TFB: p=0,0301), porém o SF-36 não foi capaz encontrar melhoras significativas nos grupos. Dessa forma, concluímos que o TFOV apresenta-se como uma estratégia relevante e segura de intervenção não farmacológica para mulheres acometidas por OA sintomática de joelhos, constituindo um modelo de tratamento capaz de induzir adaptações funcionais e morfológicas de grande interesse para esta população / Osteoarthritis (OA) of the knee is one of the most common articular disease worldwide, affecting 100,000 women in 2693 and 1770 in every 100,000 men. Although strength training (ST) is widely recommended for improving the physical weaknesses found in patients with OA, using loads between 70-85% of maximal dynamic strength (MDS) can be limited not only by pain, but also by the own etiology of the disease, representing a limitation of this practice. Strength training associated with vascular occlusion (STVO) is based on the execution of the ST at intensities between 20 and 50% of MDS, combined with the occlusion of blood flow through the use of tourniquets. Studies have shown that the magnitude of changes in strength and muscle mass after a period of training this technique is similar to those caused by high-intensity ST (MDS 70-85%) without the addition of the vascular occlusion. The objective of this study was to investigate the efficacy of the combination of vascular occlusion to the ST as non pharmacologic intervention model for improving pain, muscle strength, functionality and quality of life in patients diagnosed with knee OA. Thus, 48 women participants were randomly divided into three groups: strength training low intensity (STL), strength training, high intensity (STH) or low-intensity strength training associated with vascular occlusion (STVO) and trained two times per week for twelve weeks. At baseline and after the intervention, the patients underwent physical assessments (tests of functionality and strength), answered questionnaires on quality of life and pain (WOMAC index \"Western Ontario and McMaster Universities Osteoarthritis Index\" and SF-36 \"The Short form 36 Health Survey \") and the cross section area (CSA) of the quadriceps muscle was assessed using computed tomography. During the training period the STH group, four patients were excluded from the protocol due to knee pain. After the intervention, the WOMAC, only the STVO and STL groups showed significant decreases in pain (p=0.0358 and p=0.0044, respectively), in other domains, the only group that showed significant decreases in score was the STVO (stiffness: p= 0.0167 and p = 0.0358 functionality). In functionality testing, the STVO and STH groups showed significant increases in performance \"Timed-stands test\" (p=0.0251 and p=0.003), the \"Timed-up-and-go\" were not significant improvements found in groups. Regarding strength, only the STVO and STH groups significantly increased values in leg press (p<0.0001) and knee extension (p<0.0001). Similar behavior was found in increased AST and STH STVO groups showed significant increases (p<0.0001). The improvement of quality of life was significant in all three groups when analyzing the sum of the domains of WOMAC (STVO: p=0.0173; STH: p=0.0438; STL: p=0.0301), but the SF-36 was not able to find significant improvements in groups. Thus, we conclude that the STVO presents itself as a relevant and safe strategy of non-pharmacological intervention for women suffering from symptomatic knee OA, constituting a model of treatment capable of inducing functional and morphological adaptations of great interest to this population

O objetivo deste estudo foi adaptar e validar o Foot Health Status Questionnaire (FHSQ) avaliando suas propriedades de medida. Este instrumento foi traduzido, traduzido de volta para o inglês, avaliado por comitê multidisciplinar e submetido a pré-teste, gerando o FHSQ-Br. O FHSQ-Br foi submetido a teste de campo em um grupo de estudo composto por 65 pacientes com Artrite Reumatóide (AR) para avaliar a confiabilidade teste-reteste, a consistência interna e a validade do construto. A validade do construto foi testada correlacionando os escores do instrumento com dados clínicos e laboratoriais usados para avaliar a AR. Este estudo demonstrou que o FHSQ-Br é um instrumento confiável, consistente e válido, útil na avaliação da saúde dos pés, sendo passível de adaptação para diferentes culturas / The purpose of this study was to conduct a cross-cultural adaptation and validation of the Foot Health Status Questionnaire (FHSQ) evaluating its measurement properties. All ten domains of the FHSQ were translated into Portuguese by two Brazilian translators creating Version 1. This version was back-translated by two native English-speaking teachers who made suggestions for Version 1, creating Version 2. A multidisciplinary committee was formed to test the instrument’s semantic, idiomatic, experiential and conceptual equivalences. After being reformulated and approved by the committee, Version 3 was pre-tested on a group of patients from the Rheumatology Service of the Hospital das Clínicas. They answered this version and made suggestions for the better understanding of the instructions, questions and response option. The FHSQ-Br was then created. The translated and adapted version was submitted to field test on a study group composed of sixty-five Rheumatoid Arthritis (RA) patients to evaluate test-retest reliability, internal consistency and construct validity. The construct validity of the FHSQ-Br was tested correlating the scores to clinical and laboratory parameters commonly used to assess RA (Health Assessment Questionnaire; Numbered Rating Scale for foot pain; foot X-rays; erythrocyte sedimentation rate and C-reactive protein). The cultural adaptation of the FHSQ was successfully accomplished, since patients suggested changes in only three items of the instrument during the pre-test phase. In the field test, the intra-class correlation coefficients showed high reliability for both intra- and inter-observer correlations. Internal consistency coefficients were statistically significant (p<0.05) for all domains. As for the evaluation of the construct validity, each domain revealed correlations with a specific group of parameters, according to what the domains were intended to measure. The FHSQ was cross-culturally adapted generating a reliable, consistent and valid instrument. This study has proven the FHSQ-Br to be a useful tool to evaluate foot health in systemic diseases and is easily adaptable to different cultures

As metaloproteinases são abundantes em venenos de serpentes. Estas enzimas são homólogas às de mamíferos, encontradas em níveis elevados em inflamações articulares. Neste estudo avaliou-se a capacidade da BaP1, induzir: i) a inflamação e incapacitação articulares e a participação do TNF-<font face=\"symbol\">a e PGE2 nesses efeitos e ii) a ativação de macrófagos em cultura e a natureza de sua interação com estas células. A BaP1 induziu aumento da permeabilidade vascular, liberação de TNF-<font face=\"symbol\">a, MMP-9 e PGE2 e acúmulo de leucócitos na cavidade articular e tecido sinovial. Ainda, induziu dor articular. O pré-tratamento dos animais com indometacina ou anti-TNF-<font face=\"symbol\">a reduziu a dor e o influxo leucocitário, induzidos pela BaP1. A BaP1 induziu a expressão de COX-2 e de TNF-<font face=\"symbol\">a e a liberação desta citocina, em macrófagos isolados. Nestas células detectou-se a internalização da BaP1. Em conclusão, a BaP1 induz inflamação e nocicepção articulares, dependentes de TNF-<font face=\"symbol\">a e PGE2. A COX-2 deve estar envolvida na liberação de PGE2 e os macrófagos são alvos importantes para as ações dessa metaloproteinase. / Metalloproteinases are major enzymes in snake venoms showing high grade of homology with mammal matrix metalloproteinases, present in high levels in inflamed joints. In this study we examined the ability of BaP1, to induce: i) inflammation and hypernociception in rat articular joints and participation of TNF-<font face=\"symbol\">a and PGE2 in these effects, and ii) activation of cultured macrophages. BaP1 increased vascular permeability, induced release of TNF-<font face=\"symbol\">a, PGE2 and pro-MMP-9 in joint cavities, and leucocyte influx into joint cavities and synovial tissues. Moreover, BaP1 induced articular hypernociception. Treatment of animals with indomethacin or antiserum anti-TNF-<font face=\"symbol\">a significantly reduced hypernociception and leukocyte influx induced by BaP1. Incubation of macrophages with BaP1 caused expression of TNF-<font face=\"symbol\">a and COX-2 as well as TNF-<font face=\"symbol\">a release. In conclusion, BaP1 induces inflammation and hypernociception in articular joints. These effects are dependent on PGE2 and TNF-<font face=\"symbol\">a. COX-2 may contribute for BaP1-induced PGE2 release and macrophages are key targets for BaP1 induced effects.

by Cecilia Li Tsang Wai Ping. / Thesis (M.Phil.)--Chinese University of Hong Kong, 1993. / Includes bibliographical references (leaves [175-185]). / ABSTRACT / AKNOWLEDGEMENTS / Chapter CHAPTER ONE --- INTRODUCTION / Chapter 1.1 --- INTRODUCTION --- p.1 / Chapter 1.2 --- AIMS OF STUDY --- p.3 / Chapter CHAPTER TWO --- RHEUMATOID ARTHRITIS / Chapter 2.1 --- DEFINITION --- p.4 / Chapter 2.2 --- PREVALENCE --- p.4 / Chapter 2.3 --- AETIOLOGY --- p.4 / Chapter 2.4 --- PATHOLOGY --- p.5 / Chapter 2.5 --- CLINICAL FEATURES OF RHEUMATOID ARTHRITIS IN HAND --- p.5 / Chapter 2.6 --- CRITERIA FOR DIAGNOSIS OF RHEUMATOID ARTHRITIS --- p.7 / Chapter CHAPTER THREE --- HAND DEFORMITIES IN RHEUMATOID ARTHRITIS / Chapter 3.1 --- THE HAND --- p.9 / Chapter 3.2 --- THE RHEUMATOID HAND --- p.13 / Chapter 3.4 --- CAUSES OF FLEXION CONTRACTURE AT THE PROXIMAL INTERPHALANEAL JOINT --- p.16 / Chapter CHAPTER FOUR --- SPLINTING FOR THE RHEUMATOID HAND / Chapter 4.1 --- SPLINTING IN RHEUMATOID ARTHRITIS --- p.19 / Chapter 4.2 --- SPLINTING FLEXION CONTRACTURES AT THE PROXIMAL INTERPHALANGEAL (PIP) JOINTS --- p.24 / Chapter 4.3 --- THE MECHANICAL ANALYSIS OF SPLINT DESIGN --- p.32 / Chapter CHAPTER FIVE --- HAND ASSESSMENT IN RHEUMATOID ARTHRITIS / Chapter 5.1 --- INTRODUCTION --- p.41 / Chapter 5.2 --- A REVIEW OF THE STANDARDISED HAND FUNCTION ASSESSMENT --- p.42 / Chapter 5.3 --- MEASUREMENT OF GRIP STRENGTHS --- p.48 / Chapter 5.4 --- MEASUREMENT OF ACTIVE RANGE OF MOTION OF FINGER JOINTS --- p.52 / Chapter CHAPTER SIX --- DEVELOPMENT OF HAND EVALUATION SYSTEM in RHEUMATOID ARTHRITIS / Chapter 6.1 --- INTRODUCTION --- p.56 / Chapter 6.2 --- AIMS OF STUDY --- p.56 / Chapter 6.3 --- DEVELOPMENT OF THE HAND EVALUATION SYSTEM --- p.57 / Chapter 6.4 --- A COMPARATIVE STUDY OF HAND GRIP ASSESSMENT TOOLS: THE JAMAR DYNAMOMETER AND THE REC PROTOTYPE GRIP ANALYSER --- p.58 / Chapter 6.5 --- A COMPARATIVE STUDY ON THE JEBSEN HAND FUNCTION TEST IN HONG KONG --- p.67 / Chapter 6.6 --- ASSESSMENT OF FUNCTIONAL RANGE OF MOTION --- p.77 / Chapter 6.7 --- CONCLUSION --- p.83 / Chapter CHAPTER SEVEN --- THE MAIN STUDY / Chapter 7.1 --- INTRODUCTION --- p.85 / Chapter 7.2 --- RESEARCH DESIGN --- p.85 / Chapter 7.3 --- DEFINITION OF VARIABLES --- p.86 / Chapter 7.4 --- SUBJECT SELECTION --- p.89 / Chapter 7.5 --- EXPERIMENTAL PROCEDURES --- p.89 / Chapter 7.6 --- PILOT STUDY --- p.91 / Chapter 7.7 --- STATISTICAL ANALYSIS OF DATA --- p.94 / Chapter CHAPTER EIGHT --- RESULTS / Chapter 8.1 --- RESULTS --- p.95 / Chapter 8.1.1 --- Age distribution --- p.96 / Chapter 8.1.2 --- Occupation --- p.98 / Chapter 8.1.3 --- Functional class --- p.98 / Chapter 8.1.4 --- Group characteristics --- p.99 / Chapter 8.1.5 --- Comparison of the effect of corrective splints on hand functions of clients --- p.100 / Chapter 8.1.6 --- Comparison of the effect of two types of corrective splintage on hand functions of clients --- p.103 / Chapter 8.2 --- SUMMARY --- p.113 / Chapter 8.2.1 --- Summary of findings --- p.113 / Chapter 8.2.2 --- Compliance and complication of the splint intervention programme --- p.114 / Chapter CHAPTER NINE --- DISCUSSION / Chapter 9.1 --- INTRODUCTION --- p.116 / Chapter 9.2 --- COMMENTS ON THE HAND EVALUATION PROTOCOL … --- p.117 / Chapter 9.3 --- DISCUSSIONS OF THE RESULTS OF THE PILOT STUDY --- p.121 / Chapter 9.4 --- DISCUSSION OF THE RESULTS OF THE MAIN STUDY --- p.125 / Chapter 9.5 --- IMPLICATION OF STUDY INTO OCCUPATIONAL THERAPY PRACTICE --- p.130 / Chapter 9.6 --- LIMITATION OF THE STUDY --- p.131 / Chapter 9.7 --- SUMMARY --- p.132 / Chapter CHAPTER TEN --- CONCLUSION AND RECOMMENDATIONS / Chapter 10.1 --- CONCLUSION --- p.134 / Chapter 10.2 --- RECOMMENDATIONS --- p.138 / Chapter 10.3 --- SUGGESTIONS FOR FURTHER RESEARCH --- p.139 / APPENDICES / REFERENCES

Despite the development of new biomarkers predicting prognosis in rheumatoid arthritis (RA) remains challenging and targeting of powerful biologics difficult. The presence of ectopic germinal centres (GC) within synovium has long been recognised (ectopic lymphoneogenesis [ELN]) and data have suggested that they manufacture antibody (Ab). High affinity class switched Ab production occurs through class switch recombination (CSR) and somatic hypermutation (SHM) both critically dependent on activation induced cytidine deaminase (AID). However, whether ectopic GCs express AID has not been known. Nonetheless data associating ELN with disease severity suggest a role for ELN in RA pathogenesis and as a potential biomarker. A classification system for RA synovium, based on the concept of ELN has been proposed as: (i) aggregate, (ii) aggregate GC+ and, (iii) an unorganised infiltrate. However whether these distinct pathotypes and/or degree of aggregation equate to disease severity is unclear. Thus my first aim was to develop and validate a pathological scoring system for rheumatoid synovium capable of quantifying the degree of ELN. My second aim was to investigate whether the presence and/or degree of ELN within the synovial membrane correlated with both clinical phenotype and predicted erosive damage. I demonstrate that the aggregational score developed is highly reliable and that ELN within synovial tissue associates with a higher level of synovial inflammation but is not predictive of damage. My third aim was to investigate whether GCs within RA synovium were functional. I provide evidence of functionality by demonstrating that ectopic GCs invariably express AID, are surrounded by anti-CCP+ plasma cells, support ongoing CSR and the manufacture of anti-CCP Abs. My final aim was to characterise a cohort of synovial B cells consistently found surrounding ectopic GCs. I identify a novel B cell subset within RA synovium, interfollicular large B cells, (5)(5)(5) and demonstrate that interfollicular large B cells in lymph node express a somatically mutated IgH.

The ubiquitous ɣ-herpesvirus Epstein-Barr virus (EBV) infects B cells and modifies their differentiation programme leading to B cell activation and immortalization. Although different evidences support a link between EBV infection and rheumatoid arthritis (RA) and Sjogren’s syndrome (SS), the exact role of EBV in RA and SS pathogenesis remain elusive. Recently ectopic lymphoid structures (ELS) have been identified as preferential niches for EBV persistence and reactivation in patients with multiple sclerosis and myasthenia gravis. Independent studies demonstrated that around 50% of RA synovia and 30% of SS salivary glands are characterised by the development of functional ELS, capable to promote local differentiation of autoreactive plasma cells. In this PhD project I explored the potential role of EBV in RA and SS pathogenesis by analysing EBV infection in the RA synovium and SS salivary glands and its relationship with ELS, in situ autoreactive plasma cell differentiation, pathogenic autoantibodies production and cytotoxic immune response. In this work I demonstrated that: i) markers of EBV latent and lytic infection are consistently associated with the presence of ELS in the RA synovium and SS salivary glands; ii) latent EBV proteins are preferentially expressed by B cells, while viral reactivation occurs in plasma cells; iii) a large subset of autoreactive plasma cells is EBV lytically infected in the RA synovia and SS salivary glands; iv) antibodies specific for unmodified and citrullinated EBV peptides, known to cross-recognize ACPA, are produced within ectopic lymphoid structures as 8 demonstrated in vivo in human RA/SCID chimeras; v) SS salivary gland grafts transplanted into SCID mice release human IgG against EBV antigens, whose production correlates with the level of SS-associated auto-antibodies and vi) analysis of CD8+ and CD4+ T-cell localization and granzyme B expression indicated that EBV persistence in ELS-containing RA synovia and SS salivary glands may be favoured by exclusion of CD8+ T cells from B-cell follicles and impaired CD8-mediated cytotoxicity. Overall, these results redefine a novel and pathogenically relevant role for EBV in B-cell dysregulation and chronic inflammation in RA synovium and SS salivary glands.

Iron plays a potential role in oxidative stress-mediated injuries and pathologies e.g. rheumatoid arthritis (RA). Four decades ago it was suggested that iron may have a crucial role in the progression of inflammation in RA. Indeed, free radicals generated by iron can cause damage to lipids, proteins, carbohydrates, and DNA. It is this destructive process that is believed to occur in rheumatoid joints. However, none had differentiated between the role of iron in both acute and chronic phases of the disease and the origin of this 'labile' iron. Since RA cells are chronically exposed to oxidative stress, we have therefore chosen Jurkat cells to be our cell model. We used the parental (J16) cell line was used to mimic the acute phase of oxidative stress and the H2O2-resistant (HJ16) cells to mimic the chronic phase. By using hydrogen peroxide (H2O2) as the oxidising agent, we aim to study the role of iron in acute and chronic phase of oxidative stress and to know its origin. In the present study, we found that both antioxidants and H2O2-induced labile iron are modulated when cells are chronically exposed to H2O2. HJ16 cells contain higher total intracellular glutathione levels and glutathione peroxidase activity than J16 cells while the superoxide dismutase and catalase activity are similar. Haem oxygenase-1 (HO-1) was not detectable nor was it induced in these cell lines; HO-2 on the other hand was expressed but not induced. Although they had the same ‘basal’ LIP and L-Ft levels, J16 cells contain more than 7-fold higher H-Ft levels than in HJ16 cells. It was also found that H2O2-induced labile iron is directly correlated with necrotic cell death. These results are consistent with the conclusion that both antioxidant defence mechanism and labile iron status are modulated in cells chronically exposed to H2O2. We have also shown that the ‘basal’ and ‘H2O2-induced’ NFκB activation was higher in the HJ16 cells. We have also provided a link between labile iron release, lysosomal membrane damage and the ensuing necrotic cell death following H2O2 treatment.